Morgan Stanley Maintains Overweight on CME Group, Raises Price Target to $359
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice TargetHot
Morgan Stanley analyst Michael Cyprys maintains CME Group (NASDAQ:CME) with a Overweight and raises the price target from $337 to $359.
Morgan Stanley analyst Michael Cyprys maintains CME Group (NASDAQ:CME) with a Overweight and raises the price target from $337 to $359.